380
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Identification of a novel splice variant in SEC23B gene in a patient with concomitant presence of congenital dyserythropoietic anemia II and Gilbert’s syndrome

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2343163 | Received 29 Nov 2023, Accepted 07 Apr 2024, Published online: 24 Apr 2024

References

  • Iolascon A, Andolfo I, Russo R. Congenital dyserythropoietic anemias. Blood. 2020;136:1274–1283. doi:10.1182/blood.2019000948
  • Russo R, Gambale A, Langella C, et al. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores. Am J Hematol. 2014;89:E169–E175. doi:10.1002/ajh.23800
  • Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–D10D7. doi:10.1093/nar/gkx1153
  • Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi:10.1038/gim.2015.30
  • Li D, Li B, Qu S, et al. Analysis of genotype and phenotype of SEC23B gene in a family affected with congenital dyserythropoietic anemia type II. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017;34:874–878.
  • Desmet FO, Hamroun D, Lalande M, et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67. doi:10.1093/nar/gkp215
  • Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535–548. doi:10.1016/j.cell.2018.12.015
  • Bianchi P, Schwarz K, Hogel J, et al. Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations. Br J Haematol. 2016;175:696–704. doi:10.1111/bjh.14271
  • Bolton-Maggs PH, Langer JC, Iolascon A, et al. General haematology task force of the British committee for standards in H. guidelines for the diagnosis and management of hereditary spherocytosis–2011 update. Br J Haematol. 2012;156:37–49. doi:10.1111/j.1365-2141.2011.08921.x
  • Russo R, Marra R, Rosato BE, et al. Genetics and genomics approaches for diagnosis and research into hereditary anemias. Front Physiol. 2020;11:613559. doi:10.3389/fphys.2020.613559
  • Russo R, Andolfo I, Manna F, et al. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018;93:672–682. doi:10.1002/ajh.25058
  • Musri MM, Venturi V, Ferrer-Cortes X, et al. New cases and mutations in SEC23B gene causing congenital dyserythropoietic anemia type II. Int J Mol Sci. 2023;24(12):24.
  • Russo R, Esposito MR, Asci R, et al. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene. Am J Hematol. 2010;85:915–920. doi:10.1002/ajh.21866
  • Anna A, Monika G. Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet. 2018;59:253–268. doi:10.1007/s13353-018-0444-7
  • Takahara K, Schwarze U, Imamura Y, et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet. 2002;71:451–465. doi:10.1086/342099
  • Symoens S, Malfait F, Vlummens P, et al. A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement. PLoS One. 2011;6:e20121. doi:10.1371/journal.pone.0020121
  • Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica. 2012;97:1786–1794. doi:10.3324/haematol.2012.072207
  • Aydin Koker S, Karapinar TH, Oymak Y, et al. Identification of a novel mutation in the SEC23B gene associated with congenital dyserythropoietic anemia type II through the use of next-generation sequencing panel in an undiagnosed case of nonimmune hereditary hemolytic anemia. J Pediatr Hematol Oncol. 2018;40:e421–e4e3. doi:10.1097/MPH.0000000000001207
  • Russo R, Langella C, Esposito MR, et al. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II. Blood Cells Mol Dis. 2013;51:17–21. doi:10.1016/j.bcmd.2013.02.003
  • Perrotta S, del Giudice EM, Carbone R, et al. Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II). J Pediatr. 2000;136:556–559. doi:10.1016/S0022-3476(00)90026-X